A hemostatic powder, TC-325 (Hemospray), worked as well as standard treatment for endoscopic control of acute bleeds from nonvariceal upper gastrointestinal lesions, a randomized trial found. In the ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S.

BLOOMINGTON, Ind.--(BUSINESS WIRE)--A new, multicenter study on Cook Medical’s Hemospray Endoscopic Hemostat device was published in the April 2019 edition of Gastrointestinal Endoscopy. The ...

A next-generation hemostatic powder that stops bleeding one second after being applied has been developed. It is expected to greatly help combatants who die from excessive bleeding in war. KAIST ...

SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...

The global Hemostats Market is projected to reach a value of $2.7 billion by 2025 and is expected to experience a robust ...

The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...